Patrick Connor Johnson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphoma, Follicular | 1 | 2024 | 460 | 0.680 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2023 | 1642 | 0.480 |
Why?
|
| Quality of Life | 3 | 2024 | 13510 | 0.260 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2022 | 631 | 0.170 |
Why?
|
| Plasmacytoma | 1 | 2019 | 170 | 0.150 |
Why?
|
| Europe | 1 | 2024 | 3441 | 0.140 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2023 | 1520 | 0.130 |
Why?
|
| Geriatric Assessment | 1 | 2023 | 1422 | 0.120 |
Why?
|
| Skull Base Neoplasms | 1 | 2019 | 281 | 0.120 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1437 | 0.110 |
Why?
|
| Lymphoma | 1 | 2022 | 1900 | 0.110 |
Why?
|
| Multiple Myeloma | 2 | 2022 | 5196 | 0.100 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 1907 | 0.090 |
Why?
|
| Weight Loss | 1 | 2021 | 2721 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 3626 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 26395 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11886 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5716 | 0.060 |
Why?
|
| Aged | 3 | 2024 | 171786 | 0.050 |
Why?
|
| Adaptation, Psychological | 2 | 2023 | 2666 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 6982 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2023 | 446 | 0.040 |
Why?
|
| Humans | 9 | 2024 | 768970 | 0.040 |
Why?
|
| Neutropenia | 1 | 2022 | 893 | 0.040 |
Why?
|
| Middle Aged | 4 | 2024 | 223737 | 0.030 |
Why?
|
| United States | 1 | 2024 | 73186 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20776 | 0.030 |
Why?
|
| Female | 4 | 2024 | 397515 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 2009 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 36854 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 2059 | 0.020 |
Why?
|
| Male | 3 | 2024 | 365203 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2023 | 10115 | 0.020 |
Why?
|
| Caregivers | 1 | 2023 | 2308 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2023 | 81903 | 0.020 |
Why?
|
| Anxiety | 1 | 2022 | 4672 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 4978 | 0.020 |
Why?
|
| Depression | 1 | 2023 | 8231 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 54962 | 0.010 |
Why?
|
| Mutation | 1 | 2021 | 30266 | 0.010 |
Why?
|
| Adult | 2 | 2022 | 223851 | 0.010 |
Why?
|